Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China

Journal article

Jiang L. et al, (2010), Chin J Epidemiol, 31, 925 - 928

Cross-sectional study of statin use among high-risk patients with coronary heart disease in China

Journal article

Li J. et al, (2010), Chin Circ J, 25, 348 - 351

Survey of statin usage in 4429 diabetic patients with atherosclerostic cardiovascular disease in China

Journal article

Jiang L. et al, (2010), Chin J Cardiovasc Med, 15, 264 - 268

Aspirin for primary prevention of vascular disease in people with diabetes.

Journal article

Haynes R. et al, (2009), BMJ, 339

No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study

Conference paper

Hopewell JC. et al, (2009), CIRCULATION, 120, S606 - S606

Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials

Journal article

Rahimi K. et al, (2009), EUROPEAN HEART JOURNAL, 30, 450 - 451

Effect of statins on ventricular arrhythmic events: a collaborative meta-analysis of randomised controlled trials

Journal article

Rahimi K. et al, (2009), EUROPEAN HEART JOURNAL, 30, 591 - 591

Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants.

Journal article

Clarke R. et al, (2009), Br J Nutr, 102, 279 - 284

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.

Journal article

MRC/BHF Heart Protection Study Collaborative Group None. et al, (2009), BMC Clin Pharmacol, 9

Statin cost-effectiveness in the United States for people at different vascular risk levels.

Journal article

Heart Protection Study Collaborative Group None., (2009), Circ Cardiovasc Qual Outcomes, 2, 65 - 72

Therapeutic Strategies in Lipid Disorders

Book

Armitage J. and Bowman LJ., (2009), 15 - 28

Estimated 10-year cardiovascular risk in a British population: results of a national screening project.

Journal article

Neil HAW. et al, (2008), Int J Clin Pract, 62, 1322 - 1331

SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Journal article

SEARCH Collaborative Group None. et al, (2008), N Engl J Med, 359, 789 - 799

Regarding "Does simvastatin save lives; If so, when and in whom?" - Reply

Journal article

Bulbulia R. et al, (2008), JOURNAL OF VASCULAR SURGERY, 47, 901 - 901

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Journal article

Cholesterol Treatment Trialists' (CTT) Collaborators None. et al, (2008), Lancet, 371, 117 - 125

The impact of privacy and confidentiality laws on the conduct of clinical trials.

Conference paper

Armitage J. et al, (2008), Clin Trials, 5, 70 - 74

The safety of statins in clinical practice.

Journal article

Armitage J., (2007), Lancet, 370, 1781 - 1790

Load More